Related Articles
Window of opportunity: A new insight into sequential bevacizumab and paclitaxel in two cases of metastatic triple‑negative breast cancer
Subserous invasion of VEGF‑C‑producing cancer cells is a possible risk factor for ileal ulceration in the non‑metastatic mucosal layer during bevacizumab‑combined chemotherapy for recurrent ovarian cancer: A case report
Vascular infarction by subcutaneous application of tissue factor targeted to tumor vessels with NGR-peptides: Activity and toxicity profile
Intrapleural combination therapy with bevacizumab and cisplatin for non-small cell lung cancer‑mediated malignant pleural effusion
Complete response of lung metastases from rectal cancer to combination first‑line therapy of S‑1 and irinotecan plus bevacizumab: A case report and review of the literature